Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

December 06, 2023 00:20:43
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1
COR2ED - Oncology Medical Conversation
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

Dec 06 2023 | 00:20:43

/

Show Notes

In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute at the Icahn School of Medicine and the Blavatnik Family Chelsea Medical Center at Mount Sinai in New York, USA) and Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London, UK) discuss their experience and views on choosing the best treatment every time in multiple myeloma.

In this first episode, Dr. Richter and Dr. Ramasamy discuss how to select the best approach in newly diagnosed patients with multiple myeloma. The experts look at transplant eligibility as one of the key factors in deciding which treatment to start with in the front-line setting. They discuss the potential for personalising therapy in newly diagnosed patients, both in the transplant setting as well as in patients who are not eligible for transplantation.

They also comment on the impact of MRD negativity in clinical practice and agree that the goal of treatment is to induce deep remissions. However, which patient needs triple or quadruplet therapy to achieve this goal is still unclear and the risk-benefit profile needs to be considered for each individual patient.

The final topic that the experts share their points of view on is continuous vs fixed-duration maintenance therapy.

Other Episodes

Episode

April 15, 2025 00:21:27
Episode Cover

The HER2 Diagnostic and Treatment Landscape in NSCLC

Episode 1: Identifying HER2-directed NSCLC: The Medical Oncologist and Pathologist perspectives  This is the first episode of a two-part series on the HER2 diagnostic...

Listen

Episode

April 25, 2024 00:32:21
Episode Cover

Câncer de ovário: Desafios da fase pré-analítica e teste de biomarcadores

Quais são os desafios mais comuns na fase pré-analítica na luta contra o câncer de ovário e como podemos superá-los? Qual a importância de...

Listen

Episode

December 06, 2023 00:29:56
Episode Cover

HCC: VEGFR-TKIs alone or in combination with immune checkpoint inhibitors

In this medical education podcast episode, Prof. Peter Galle and Prof. Amit Singal discuss the use of VEGFR-TKIs in the treatment of advanced or...

Listen